ACU333: Prevalence Of Deleterious Oral Habits Among a Group of School Children in Cairo, Egypt: Cross-Sectional Study

Sponsor
Ahram Canadian University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05769166
Collaborator
(none)
1,500
30

Study Details

Study Description

Brief Summary

This study aims to detect the prevalence of practicing oral habits among a group of school children in Cairo, Egypt.

Condition or Disease Intervention/Treatment Phase
  • Other: thired domain of nordic orofcial test-screen

Detailed Description

An online questionnaire utilizing the third domain of Nordic Orofacial Test screen will be distributed among school children (aged five to seven years) parents to measure the prevalence of oral habits.

Study Design

Study Type:
Observational
Anticipated Enrollment :
1500 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Prevalence Of Deleterious Oral Habits Among a Group of School Children in Cairo, Egypt: Cross-Sectional Study
Anticipated Study Start Date :
Apr 1, 2023
Anticipated Primary Completion Date :
May 1, 2023
Anticipated Study Completion Date :
May 1, 2023

Arms and Interventions

Arm Intervention/Treatment
School children

school children aged from five to seven years

Other: thired domain of nordic orofcial test-screen
its a questionnaire which the parent will answer

Outcome Measures

Primary Outcome Measures

  1. oral habits (presence / absence) [baseline record]

    practicing one or more of the following habit(s): sucking habits, nail biting, bruxism

Eligibility Criteria

Criteria

Ages Eligible for Study:
5 Years to 7 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • school children

  • accept to participate

  • children within the age group

Exclusion Criteria:
  • special health care needs children

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Ahram Canadian University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mennat Allah Ashraf A.Elsabour, Teaching assistant, Ahram Canadian University
ClinicalTrials.gov Identifier:
NCT05769166
Other Study ID Numbers:
  • ACU 333
First Posted:
Mar 15, 2023
Last Update Posted:
Mar 15, 2023
Last Verified:
Mar 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 15, 2023